OGN
Organon & Co.Healthcare · $3.6B market cap
Verdict
Share price
$13.72
close of Oct 3, 2026
Fair value
$16.20
Sticker Price
Payback Price
$6.48
buy price
OGN is Undervalued: at $13.72 it trades 15% below its fair value of $16.20. Its buy price (Payback Price) is $6.48, 53% below today's price. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.
How we valued it
Owner Earnings. Earnings have been shrinking, but the business still generates cash, so we value it on its cash flow instead of its earnings.
Business quality
2 of 5 clear the 10% bar. What are the Big Five?
Follow OGN
Get notified when it reaches its buy price of $6.48. Free.
Create a free accountSuperinvestors
1 of the investors we track holds OGN. Who we track
Insider activity
Since Jun 12, 2026: no open-market purchases, 1 sale worth $200K and 11 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
Other filings
Arjona Ferreira Juan Camilo
Head of R&D & CMO · 2026-08-11
Tax withholding
$56K
Arjona Ferreira Juan Camilo
Head of R&D & CMO · 2026-08-11
Option exercise
11,519 shares
ESSNER ROBERT
director · 2026-06-12
Award
17,857.143 shares
Ezekowitz Alan
director · 2026-06-12
Award
17,857.143 shares
Gayle Helene D
director · 2026-06-12
Award
17,857.143 shares
Show all 11 other filingsShow fewer
LAZARUS ROCHELLE B
director · 2026-06-12
Award
17,857.143 shares
Leone Deborah R
director · 2026-06-12
Award
17,857.143 shares
Ozuah Philip
director · 2026-06-12
Award
17,857.143 shares
Patton Cynthia M
director · 2026-06-12
Award
17,857.143 shares
Sequeira Ramona
director · 2026-06-12
Award
17,857.143 shares
Sharp Shalini
director · 2026-06-12
Award
17,857.143 shares
About Organon & Co.
Organon & Co., a global pharmaceutical enterprise, is dedicated to developing and delivering a wide array of prescription therapies. Its women's health division features reproductive care products, encompassing birth control and fertility treatments, notably Nexplanon/Implanon, an extended-duration contraceptive. The company's biosimilars collection includes three immune-related medications (Brenzys, Renflexis…
Drug Manufacturers - General
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works